A unique model
IRIC, located in the heart of the Université de Montréal campus, operates according to a unique model in Canada that combines, under one roof, fundamental research activities, a university-level training program and a research maturation team. These generate discoveries that advance knowledge or that can quickly translate into new therapeutic solutions.
-
News National Philanthropy Day 2026 — Mélanie Lefebvre: Art, Research, and Hope
There are encounters that move us deeply and give us new momentum. Meeting Mélanie Lefebvre was one of them.
-
News The Cancer Research Society Supports Three Research Projects at IRIC to Explore New Therapeutic Approaches
The Cancer Research Society (CRS) has awarded three operating grants to the teams led by Geneviève Deblois, Sylvain Meloche, and Matthew J. Smith. Worth $140,000 each over two years, these grants total $420,000 and will support research on triple-negative breast cancer, pancreatic cancer, and the mechanisms that regulate cancer cell proliferation.
-
News The IRIC Community Takes Part in the 2026 “Light the night” Event!
On October 25, a team of IRIC students came together to participate in the ““Light the night” event and raise funds as a team of researchers specializing in blood cancers.
-
News A Natural Sciences and Engineering Research Council of Canada (NSERC) Alliance Grant to Advance Computational Pathology
David Knapp and Vincent Quoc-Huy Trinh, principal investigators at IRIC, are co-principal investigators on an Alliance grant awarded in May 2026 to Mahdi Hosseini, assistant professor in the Department of Computer Science and Software Engineering at Concordia University. The $4.6 million in funding supports the development of computational pathology models for preclinical studies and clinical trials of anticancer drugs.
-
News Nearly $8,000 raised through the Beneva Montreal Marathon 2026!
The 2026 Montreal Beneva Marathon took place on the weekend of October 10. As a long-standing partner of the event, IRIC raised nearly $8,000 for cancer research thanks to more than 50 generous donors.
-
News Congratulations to the winners of the 2026 Concours science réflexion !
IRIC is pleased to announce the winners of the 2026 Concours science réflexion. This annual competition showcases the creativity and talent of the IRIC community.
-
News A $1 Million Investment for RejuvenRx, the First Recipient of Stem Cell Network’s New Program
RejuvenRx, a biotechnology company co-founded by Anne Marinier and Guy Sauvageau, principal investigators at IRIC at the Université de Montréal, has been awarded a $1 million investment by Stem Cell Network (SCN).
Upcoming events
-
Upcoming May 27, 2027 Audace Gala - IRIC Fundraising Event
Since 2014, IRIC has organized the Gala Audace fundraising event, which helps fund promising discoveries in the fight against cancer each year.
The Gala Audace is much more than just an evening event: it is a time for sharing, solidarity, and hope. Let’s unite our generous hearts to support therapeutic advances through cancer research.
Latest publications
See all publications-
November 11, 2026 Mediator kinase inhibition exposes a transcriptional vulnerability and synergizes with venetoclax in AML.
Aitchedji C, Moison C, Fortier S, Mendoza-Sanchez R, Gracias D, Spinella JF, Thavonekham B, MacRae T, Mayotte N, Fréchette M, Blouin-Chagnon V, Léveillé K, Chagraoui J, Ruel R, Hébert J, Marinier A, Sauvageau G
Leukemia 2026-11-11 ; -
October 24, 2026 - See all publications